Literature DB >> 19453063

Percutaneous, non-operative radio frequency ablation for haemostasis of ruptured hepatocellular carcinoma.

Jeeta Manikam1, Sanjiv Mahadeva, Khean-Lee Goh, Basri J Abdullah.   

Abstract

Spontaneous rupture and hemorrhage is a devastating complication of hepatocellular carcinoma (HCC). Results from current therapeutic modalities remain varied. Recent development of percutaneous radiofrequency ablation (RFA) in the management of this condition has shown promise. We describe 2 cases of ruptured HCC in which nonoperative, percutaneous radio frequency ablation (RFA) was successful in achieving hemostasis. The advantageous of RFA over other interventional techniques in the management of ruptured HCC are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19453063

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

Review 1.  Rupture of Hepatocellular Carcinoma: A Review of Literature.

Authors:  Srimanta K Sahu; Yogesh K Chawla; Radha K Dhiman; Virendra Singh; Ajay Duseja; Sunil Taneja; Naveen Kalra; Ujjwal Gorsi
Journal:  J Clin Exp Hepatol       Date:  2018-04-26

2.  Radiofrequency ablation and percutaneous permanent iodine-125 implantation as salvage therapy for giant recurrent sclerosing epithelioid fibrosarcoma of the chest wall: A case report.

Authors:  Shan Ke; Xue-Mei Ding; Jun Gao; Shao-Hong Wang; Jun Zhang; Jian Kong; Wen-Bing Sun
Journal:  Oncol Lett       Date:  2015-03-09       Impact factor: 2.967

3.  Liver radiofrequency ablation as emergency treatment for a ruptured hepatocellular carcinoma: a case report.

Authors:  Alessandra Bertacco; Francesco D'Amico; Maurizio Romano; Michele Finotti; Alessandro Vitale; Umberto Cillo
Journal:  J Med Case Rep       Date:  2017-03-01

Review 4.  Ruptured Hepatocellular Carcinoma: Current Status of Research.

Authors:  Feng Xia; Elijah Ndhlovu; Mingyu Zhang; Xiaoping Chen; Bixiang Zhang; Peng Zhu
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.